MedPath

Forward-looking observational study to find out the ideal time frame for integration of implants with jaw bones which underwent radiation treatment for head and neck cancer patients

Not Applicable
Conditions
Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
Registration Number
CTRI/2024/02/062855
Lead Sponsor
Tata Memorial Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patient underwent radiation to the head and neck region in an

adjuvant/ definitive setting.

2. Undergoingdental implant placement for replacement of missing teeth in

maxillary/mandibular/ reconstructed jaw as per the protocol of hospital.

3. Present with an insertion torque of =25 at the time of dental implant placement

4. Patients should have sufficient bone dimensions allowing standard sized dental implant

placement

5. Willing to report for monthly follow-ups from 3 months to 6 months

6. Willing and able to complete study interventions, assessments, and other requirements.

7. Ready to provide with Signed, written, informed consent

Exclusion Criteria

1. Non-radiated head and neck cancer patients.

2. Who have received radiation more than once to the head and neck region, prior to the

dental implant placement

3. Local/ systemic factors which may contribute to delayed osseointegration (including

those patients who are currently on oral metronomic therapy and bone-modifying agents

including bisphosphonates, denosumab and tyrosine kinase inhibitors.)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Implant stability quotient (ISQ) should be 70±5, using resonance frequency analyzing (RFA) device (PENGUIN) when measured monthly at 3rd month and 6th month.Timepoint: 3months, 6 months
Secondary Outcome Measures
NameTimeMethod
Implant stability quotient (ISQ) should be 70±5, using resonance frequency analyzing (RFA) device (PENGUIN) when measured monthly at 3rd month and 6th month.Timepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath